These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18230562)

  • 1. Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection.
    Cunha BA; McDermott B; Nausheen S
    J Chemother; 2007 Dec; 19(6):753-4. PubMed ID: 18230562
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.
    Cunha BA
    J Clin Microbiol; 2009 May; 47(5):1613. PubMed ID: 19403778
    [No Abstract]   [Full Text] [Related]  

  • 3. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Etest to determine tigecycline MICs for Enterobacter species.
    Cohen Stuart J; Mouton JW; Diederen BM; Al Naiemi N; Thijsen S; Vlaminckx BJ; Fluit AC; Leverstein-van Hall MA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2746-7. PubMed ID: 20350941
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug-resistant Combined Infections in a Liver Transplanted Patient: Case Report.
    Carraro A; Montin U; Violi P; Soldani F; Mazzi R; Merighi M; Kanani F; Concia E; Tedeschi U
    Exp Clin Transplant; 2018 Jun; 16(3):340-343. PubMed ID: 27063638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
    Vardakas KZ; Matthaiou DK; Falagas ME; Antypa E; Koteli A; Antoniadou E
    Infect Dis (Lond); 2015; 47(10):751-3. PubMed ID: 25986909
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
    DiPersio JR; Dowzicky MJ
    Int J Antimicrob Agents; 2007 May; 29(5):518-27. PubMed ID: 17376657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.
    Balandin Moreno B; Fernández Simón I; Pintado García V; Sánchez Romero I; Isidoro Fernández B; Romera Ortega MA; Alcántara Carmona S; Pérez Redondo M; Galdos Anuncibay P
    Scand J Infect Dis; 2014 Mar; 46(3):175-80. PubMed ID: 24354959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL
    Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant Klebsiella pneumoniae mediastinitis safely and effectively treated with prolonged administration of tigecycline.
    Evagelopoulou P; Myrianthefs P; Markogiannakis A; Baltopoulos G; Tsakris A
    Clin Infect Dis; 2008 Jun; 46(12):1932-3. PubMed ID: 18540810
    [No Abstract]   [Full Text] [Related]  

  • 12. Tigecycline treatment for urinary tract infections: case report and literature review.
    Drekonja DM; Johnson JR
    J Chemother; 2011 Jun; 23(3):168-70. PubMed ID: 21742587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary tract infection caused by carbapenem-resistant K. pneumoniae and P. aeruginosa.
    Olaru ID; Popoiu M; Breuil J; Aramă V; Hristea A
    Rom J Intern Med; 2011; 49(4):289-94. PubMed ID: 22568274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline dosing is critical in preventing tigecycline resistance because relative resistance is, in part, concentration dependent.
    Cunha BA
    Clin Microbiol Infect; 2015 May; 21(5):e39-40. PubMed ID: 25708550
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
    Chen PL; Yan JJ; Wu CJ; Lee HC; Chang CM; Lee NY; Ko NY; Wang LR; Shih HI; Lee CC; Ko WC
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):312-4. PubMed ID: 20846813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Klebsiella spp. to tigecycline and other selected antibiotics.
    Sekowska A; Gospodarek E
    Med Sci Monit; 2010 Jun; 16(6):BR193-6. PubMed ID: 20512088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
    He F; Fu Y; Chen Q; Ruan Z; Hua X; Zhou H; Yu Y
    PLoS One; 2015; 10(3):e0119064. PubMed ID: 25734903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains.
    Chevalier J; Bredin J; Mahamoud A; Malléa M; Barbe J; Pagès JM
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1043-6. PubMed ID: 14982806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Options for treating carbapenem-resistant Enterobacteriaceae.
    Rafailidis PI; Falagas ME
    Curr Opin Infect Dis; 2014 Dec; 27(6):479-83. PubMed ID: 25259809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation.
    Nix DE; Matthias KR
    J Antimicrob Chemother; 2010 Jun; 65(6):1311-2. PubMed ID: 20378673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.